Skip to main content
Clinical Trials/NL-OMON45316
NL-OMON45316CompletedNot Applicable

Hemostasis in pediatric patients undergoing orthotopic liver transplantation: a prospective cohort study. - HIP-OLT

niversitair Medisch Centrum Groningen0 sites50 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50

Study Overview

Brief Summary

Trial is onging in other countries

Study Design

Study Type
Observational

Eligibility Criteria

Ages
2 to 17 (—)

Inclusion Criteria

  • Study group
  • - Patients that undergo orthotopic liver transplantation for any reason at the UMCG, except patients with acute liver failure
  • - Livers from all sort of donors will be included, including living donor livers
  • - In the period from june 2017 to june 2018
  • - Signed informed consent (patients and/or parents/guardian);Control group
  • - Healthy patients that undergo minor surgery at the UMCG
  • Minor surgery includes inguinal operations and excision of soft tissue tumours other than malignancy, like a cyst, hemangioma or lipoma.
  • - In the period from june 2017 to june 2018
  • - Matched 2:1 with the study group population for age
  • - Signed informed consent (patients and/or parents/guardian)

Exclusion Criteria

  • Study group
  • - Age > 16 years
  • - No informed consent obtained
  • - Diagnose of acute liver failure;Control group
  • - Age > 16 years
  • - No informed consent obtained
  • - Any comorbidities or pre-term birth
  • - Use of medication that influences liver function or hemostasis
  • - History of thrombotic events or bleeding

Investigators

Similar Trials

Hemostasis in pediatric patients... | Clinical Trial